Herpes Simplex Virus, Type 1&2, Qualitative, Real‐Time PCR : 34257

**This test is not available for New York patient testing**

HSVPQL or 34257

HSV 1 and HSV 2

1 mL CSF, pleural fluid, amniotic fluid or pericardial fluid collected in a sterile leak-proof container
-OR-
Serum
-OR-
Whole blood or plasma collected in: EDTA (lavender-top) tube
-OR-
1 Swab collected in a viral transport media, VCM or M4
-OR-
0.5 mL undiluted vitreous eye fluid collected in a sterile, leak-proof container

0.3 mL (0.35 BAL or bronchial wash; 0.25 undiluted vitreous eye fluid)
 

1 mL bronchoalveolar lavage or bronchial wash collected in a sterile, leak-proof container

Refrigerated
 

Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 30 days (whole blood unacceptable)

Sunday - Saturday

1-3 days

Laboratory test results should always be considered in the context of clinical observations. This test was developed and its performance characteristics determined by med fusion. It has not been cleared or approved by the U.S. Food and Drug Administration  (FDA). The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments  of 1988 (CLIA) as qualified to perform high complexity clinical laboratory testing.

Not Detected

Herpes Simplex Virus, Type 1 and 2 DNA, Qualitative, Real-Time PCR - DNA testing is analytically more sensitive than culture, especially in patients with encephalitis or meningitis. DNA testing may be useful in diagnosis of infection in neonates. Neonates who have been exposed to HSV can develop disseminated infection and encephalitis. Encephalitis is usually due to HSV I whereas meningitis is usually due to HSV II. DNA testing provides reliable means to define the type.